Literature DB >> 20479199

Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose.

Juan Luis Rodriguez-Tudela1, Alicia Gomez-Lopez, Maiken C Arendrup, Guillermo Garcia-Effron, David S Perlin, Cornelia Lass-Flörl, Manuel Cuenca-Estrella.   

Abstract

According to the product insert for Cancidas (caspofungin acetate), the drug must not be diluted in solutions containing glucose as this decreases caspofungin stability. The aim of this study was to compare caspofungin MICs for a collection of yeasts by means of EUCAST method EDef7.1 but using two different concentrations of glucose: 2% versus 0.2%. MICs were identical or within one 2-fold dilution for 93 out of 95 strains (97.9%), showing that glucose does not interfere with susceptibility.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20479199      PMCID： PMC2897297          DOI： 10.1128/AAC.00597-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.

Authors:  Manuel Cuenca-Estrella; Wendy Lee-Yang; Meral A Ciblak; Beth A Arthington-Skaggs; Emilia Mellado; David W Warnock; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.

Authors:  Maiken Cavling Arendrup; Guillermo Garcia-Effron; Cornelia Lass-Flörl; Alicia Gomez Lopez; Juan-Luis Rodriguez-Tudela; Manuel Cuenca-Estrella; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

3.  Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).

Authors:  Juan Luis Rodriguez-Tudela; J Peter Donnelly; Michael A Pfaller; Erja Chryssantou; Peter Warn; David W Denning; Ana Espinel-Ingroff; Francesco Barchiesi; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

4.  In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948
  4 in total
  3 in total

1.  Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.

Authors:  Maiken Cavling Arendrup; Juan-Luis Rodriguez-Tudela; Steven Park; Guillermo Garcia-Effron; Guillaume Delmas; Manuel Cuenca-Estrella; Alicia Gomez-Lopez; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

2.  Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance.

Authors:  Catiana Dudiuk; Soledad Gamarra; Florencia Leonardeli; Cristina Jimenez-Ortigosa; Roxana G Vitale; Javier Afeltra; David S Perlin; Guillermo Garcia-Effron
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

3.  zzm321990 Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates.

Authors:  Emilia Gómez-Molero; Iker De-la-Pinta; Jordan Fernández-Pereira; Uwe Groß; Michael Weig; Guillermo Quindós; Piet W J de Groot; Oliver Bader
Journal:  J Fungi (Basel)       Date:  2021-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.